Sobi named UK’s top haemophilia company
Tops IPC Associates’ 2016 ranking
Read More
Author: Dominic Tyer
FDA to fast-track Pfizer/Sangamo gene therapy orphan drug
SB-525 is being developed to treat haemophilia A
Read More
Aspen Pharmacare hit by EU antitrust cancer drug price probe
European regulators will investigate pricing of five oncology treatments
Read More
NHS could save £67 million a year if smoking rates cut
But would need rates to drop to 5 percent
Read More
ReNeuron wins £1.8 million for cell therapy development
Innovate UK grant will help advance its manufacturing capabilities
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
